Editorial

DOI: 10.4244/EIJ-D-26-00196

Is the stress aortic valve index a fractional flow reserve for the stenotic aortic valve?

Morton J. Kern1,2, MD; Derek Antoku1,2, MD

In patients with severe aortic stenosis (AS), aortic valve replacement (AVR), performed percutaneously or by surgery, is truly life-changing. However, in patients with moderate or mild AS, decision-making can be vexing as the optimal treatment remains unclear. Uncertainty around the need for valve replacement in such patients is especially keen in those who have dyspnoea, chest pain, or presyncope that cannot be completely attributed to the aortic valve. Moreover, evidence suggesting that moderate AS is associated with increased morbidity and mortality12 makes the decision for AVR even more poignant.

In this issue of EuroIntervention, Eerdekens et al examine the haemodynamic and clinical outcomes of a blinded, prospective, observational cohort of 52 patients with symptomatic moderate or mild aortic stenosis and preserved left ventricular (LV) function3. They tested the hypothesis that the stress aortic valve index (SAVI), defined as the aortic/left ventricular pressure ratio during dobutamine stress, would distinguish physiological responses beyond traditional valve metrics, better identifying patients for AVR who otherwise might not be treated appropriately.

The study group underwent echocardiography and transvalvular haemodynamic testing at rest, during bicycle...

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Volume 22 Number 6
Mar 16, 2026
Volume 22 Number 6
View full issue


Key metrics

Suggested by Cory

Original Research

10.4244/EIJ-D-25-00331 May 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access

Original Research

10.4244/EIJ-D-25-01370 Jun 1, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
Trending articles
334.7

State-of-the-Art Review

10.4244/EIJ-D-21-00904 Apr 1, 2022
Antiplatelet therapy after percutaneous coronary intervention
Angiolillo D et al
free
84.05

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
45.75

State-of-the-Art

10.4244/EIJ-D-25-01346 May 4, 2026
Slow flow and no reflow after percutaneous coronary intervention
Brugaletta S et al
free
42.15

State-of-the-Art

10.4244/EIJ-D-25-00896 Apr 6, 2026
Pretreatment with antiplatelet agents in patients undergoing coronary revascularisation
Kaur G et al
free
38.2

State-of-the-Art

10.4244/EIJ-D-24-00195 Apr 7, 2025
Percutaneous coronary intervention for calcified and resistant lesions
Pesarini G et al
free
33.5

Original Research

10.4244/EIJ-D-26-00032 May 15, 2026
Glucocorticoids to reduce permanent pacemaker implantation after TAVI: the GLUCO-TAVI randomised trial
Fuertes-Kenneally L et al
32.2

State-of-the-Art

10.4244/EIJ-D-25-00874 Jun 1, 2026
TAVI and coronary interventions: indications, technical considerations, and clinical scenarios
Aquino Bruno H et al
free
29.2

Original Research

10.4244/EIJ-D-25-01370 May 21, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
29.2

Original Research

10.4244/EIJ-D-25-01370 Jun 1, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
X

PCR
Impact factor: 9.2
2025 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2026)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved